<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Puma Biotechnology Inc (PBYI)</title>
    <description>Latest news, press releases, and SEC filings for Puma Biotechnology Inc (PBYI)</description>
    <link>https://caymanjournal.com/stock/PBYI</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Mon, 27 Apr 2026 20:24:31 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/PBYI/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>PRE 14A — PUMA BIOTECHNOLOGY, INC.</title>
      <description># 🧾 What This Document Is
This is a **preliminary proxy statement (PRE 14A)** for Puma Biotechnology. It’s like an &quot;information packet and ballot&quot; sent to shareholders before the annual meeting. Its job is to explain what will be voted on and provide the details shareholders need to make informed d</description>
      <link>https://caymanjournal.com/stock/PBYI/sec-filing/0001437749-26-011631</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/PBYI/sec-filing/0001437749-26-011631</guid>
      <pubDate>Tue, 07 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>